Acadia Healthcare Company, Inc. (ACHC) Stock AnalysisACHCStock AnalysisAcadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates in the Healthcare sector (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC industry).

Acadia Healthcare is currently priced at $28.55, which is significantly below the analyst price target of $39 from Guggenheim, suggesting potential upside. However, the company has a troubling forward P/E of 21.41, indicating that it may be overvalued relative to its earnings prospects. Additionally, insider selling has increased by 194.77% over the last quarter, which raises concerns about management's confidence in the company's future. Therefore, while there is potential for growth, the risks associated with current performance and insider activity suggest a cautious approach.

17 analysts cover ACHC: 10 rate it Buy, 7 Hold and 0 Sell. The average price target is 18.10.